# The Impact of CYP2D6 Polymorphism on Tramadol Pharmacodynamics

> **NCT06814652** · — · ACTIVE_NOT_RECRUITING · sponsor: **Elweyia Maternity Teaching Hospital** · enrollment: 40 (actual)

## Conditions studied

- Post-cesarean Pain
- CYP2D6 Polymorphism
- Tramadol Resistance

## Interventions

- **DRUG:** Trodon® Hemofarm

## Key facts

- **NCT ID:** NCT06814652
- **Lead sponsor:** Elweyia Maternity Teaching Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-22
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-03-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814652, "The Impact of CYP2D6 Polymorphism on Tramadol Pharmacodynamics". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06814652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*